HK1004469A1 - Apoptosis regulator - Google Patents

Apoptosis regulator

Info

Publication number
HK1004469A1
HK1004469A1 HK98103654A HK98103654A HK1004469A1 HK 1004469 A1 HK1004469 A1 HK 1004469A1 HK 98103654 A HK98103654 A HK 98103654A HK 98103654 A HK98103654 A HK 98103654A HK 1004469 A1 HK1004469 A1 HK 1004469A1
Authority
HK
Hong Kong
Prior art keywords
apoptosis regulator
apoptosis
regulator
Prior art date
Application number
HK98103654A
Other languages
English (en)
Inventor
Satoru Nakai
Koutoku Aihara
Hitomi Mori
Michiaki Tominaga
Masakazu Adachi
Hiroyuki Ichikawa
Seiji Akamatsu
Fumio Saito
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1004469A1 publication Critical patent/HK1004469A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK98103654A 1991-07-03 1998-04-29 Apoptosis regulator HK1004469A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP16258791 1991-07-03
JP3346992 1992-02-20
JP4571892 1992-03-03
JP10058592 1992-03-25
PCT/JP1992/000841 WO1993000902A1 (en) 1991-07-03 1992-07-02 Apoptosis regulator

Publications (1)

Publication Number Publication Date
HK1004469A1 true HK1004469A1 (en) 1998-11-27

Family

ID=27459795

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98103654A HK1004469A1 (en) 1991-07-03 1998-04-29 Apoptosis regulator

Country Status (12)

Country Link
US (5) US5672603A (xx)
EP (1) EP0552373B1 (xx)
KR (1) KR100196368B1 (xx)
AU (1) AU648690B2 (xx)
CA (1) CA2090876A1 (xx)
DE (1) DE69230131T2 (xx)
DK (1) DK0552373T3 (xx)
ES (1) ES2138971T3 (xx)
HK (1) HK1004469A1 (xx)
MX (1) MX9203950A (xx)
TW (1) TW229157B (xx)
WO (1) WO1993000902A1 (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2121148A1 (en) * 1992-08-19 1994-03-03 Satoru Nakai Apoptosis regulator
US5521185A (en) * 1993-03-02 1996-05-28 Otsuka Pharmaceutical Co., Ltd. Methods for inhibiting graft rejection and IL-1 production
GB9311132D0 (en) 1993-05-28 1993-07-14 Eisai London Res Lab Ltd Control of cell death
US5637597A (en) * 1993-10-21 1997-06-10 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives for inhibiting production of interleukin-8
US5504093A (en) * 1994-08-01 1996-04-02 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting nucleoside and nucleobase transport in mammalian cells, and method for inhibition of DNA virus replication
CA2185246A1 (en) * 1995-01-11 1996-07-18 Hideo Tanaka Pharmaceutical composition of indene derivatives for regulating apoptosis
WO1998046229A1 (fr) * 1995-06-21 1998-10-22 Otsuka Pharmaceutical Co., Ltd. Inhibiteurs de la production d'il-8 et du mcaf
JPH0971532A (ja) * 1995-09-06 1997-03-18 Otsuka Pharmaceut Co Ltd 発癌抑制剤
US5700803A (en) * 1995-12-12 1997-12-23 Otsuka Pharmaceutical Co., Ltd. Method for reducing infarct size in subjects afflicted with ischemic heart disease
AU6854398A (en) * 1997-04-25 1998-11-24 Otsuka Pharmaceutical Co., Ltd. Hyaluronate synthesis inhibitors
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
US6544972B1 (en) 1997-09-25 2003-04-08 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
US6281191B1 (en) 1997-12-29 2001-08-28 Vladimir I. Slesarev Compositions and methods for treating hepatitis-C
FR2774289B1 (fr) * 1998-02-03 2002-05-24 Goemar Lab Sa Medicament pour le traitement des dereglements de l'apoptose
ES2533255T3 (es) 1998-07-13 2015-04-08 Board Of Regents, The University Of Texas System Utilización de anticuerpos anti-aminofosfolípidos para el tratamiento del cáncer
SI1107795T1 (en) 1998-09-04 2003-06-30 The Regents Of The University Of Michigan Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis
US6277974B1 (en) 1999-12-14 2001-08-21 Cogent Neuroscience, Inc. Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
US20030044413A1 (en) * 2000-08-15 2003-03-06 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
WO2003053222A2 (en) * 2001-12-20 2003-07-03 Cogent Neuroscience, Inc. Methods for treating conditions, disorders, or diseases involving cell death
CN104225610B (zh) 2002-07-15 2017-03-01 得克萨斯大学体系董事会 与阴离子磷脂和氨基磷脂结合的选定抗体及其治疗用途
US20060135494A1 (en) * 2002-11-07 2006-06-22 Steer Clifford J Methods of treating injuries of the nervous system associated with hemorrhage
US8431396B2 (en) 2003-03-21 2013-04-30 The Cleveland Clinic Foundation Anti-angiogenic peptides
US20060204481A1 (en) * 2003-04-02 2006-09-14 Steer Clifford J Methods of promoting cell viability
CA2553690C (en) 2004-01-22 2016-05-24 Sung Lan Hsia Topical co-enzyme q10 formulations and methods of use
KR20080012258A (ko) * 2005-02-10 2008-02-11 리전츠 오브 더 유니버스티 오브 미네소타 시각장애를 치료하는 방법
MX2010005104A (es) 2007-11-09 2010-08-04 Peregrine Pharmaceuticals Inc Composiciones de anticuerpo anti-factor de crecimiento endotelial vascular y metodos.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5430184A (en) * 1977-08-10 1979-03-06 Otsuka Pharmaceut Co Ltd 3,4-dihydrocarbostyril derivative
JPS6038384B2 (ja) * 1978-03-24 1985-08-31 大塚製薬株式会社 チオセミカルバゾン誘導体
JPS5777676A (en) * 1980-10-31 1982-05-15 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5793962A (en) * 1980-12-01 1982-06-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
JPS62135423A (ja) * 1985-12-09 1987-06-18 Otsuka Pharmaceut Co Ltd 低酸素症改善剤

Also Published As

Publication number Publication date
EP0552373A1 (en) 1993-07-28
US5916890A (en) 1999-06-29
CA2090876A1 (en) 1993-01-04
EP0552373B1 (en) 1999-10-13
DE69230131D1 (de) 1999-11-18
WO1993000902A1 (en) 1993-01-21
EP0552373A4 (en) 1993-09-22
KR930702002A (ko) 1993-09-08
AU2231792A (en) 1993-02-11
ES2138971T3 (es) 2000-02-01
KR100196368B1 (ko) 1999-06-15
US5672603A (en) 1997-09-30
DE69230131T2 (de) 2000-03-02
DK0552373T3 (da) 1999-12-27
MX9203950A (es) 1993-05-01
US5798358A (en) 1998-08-25
TW229157B (xx) 1994-09-01
AU648690B2 (en) 1994-04-28
US5872120A (en) 1999-02-16
US5925640A (en) 1999-07-20

Similar Documents

Publication Publication Date Title
HK1004469A1 (en) Apoptosis regulator
HU9600083D0 (en) Regulated apoptosis
HU9303393D0 (en) Substituted 3-amino-quinuclidines
ZA927153B (en) Substituted 3-phenylluracils
GB9126311D0 (en) Substituted diphenylsulfides
GB9113899D0 (en) Regulating system
DE69221613D1 (en) Former
ZA924101B (en) Substituted imidazolinylpyrimidines
GB9105123D0 (en) Relaning unit
ZA923936B (en) Substituted 2-arylpyrroles
HU9201738D0 (en) Substituted 4-hetaryl-pyrazoline
EP0776359A4 (en) REGULATED APOPTOSIS
PL291212A3 (en) Dust-mask
CA68731S (en) Moneybox
AU204P (en) NIRIBI Chamelaucium uncinatum
AU206P (en) BUNDERRA Danthonia linkii
AU213P (en) MOONBEAM Galtonia candicans
AU352P (en) TRIUMPHANT Chamelaucium uncinatum
CA68506S (en) Pom-pom
CA68724S (en) Mobilier-jeu pedagogique
AU205P (en) TARANNA Danthonia richardsonii
RU1832410C (ru) Paдиoэлektpohhый блok
RU1832411C (ru) Paдиoэлektpohhый блok
ZA92974B (en) Substituted arylsulphonylaminoguanidinotriazines
ZA928677B (en) Substituted biphenlypryridones

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)